-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pii2PyMnty5ejGKeWYLGl8g+nhRpHDfDxQXLo0/GTx4jwRUdowaHqrWfCm6w9Zrq FyuBijuwJkHeMG66RjGVZQ== 0000950116-98-000563.txt : 19980310 0000950116-98-000563.hdr.sgml : 19980310 ACCESSION NUMBER: 0000950116-98-000563 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980309 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FLEMINGTON PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001043873 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407152 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-53719 FILM NUMBER: 98560399 BUSINESS ADDRESS: STREET 1: 43 EMERY AVE CITY: FLEMINGTON STATE: NJ ZIP: 08820 BUSINESS PHONE: 9087823431 MAIL ADDRESS: STREET 1: 43 EMERY AVE CITY: FLEMINGTON STATE: NJ ZIP: 08822 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MORONEY JOHN J CENTRAL INDEX KEY: 0001057265 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: NJ FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 43 EMERY AVE CITY: FLEMINGTON STATE: NJ ZIP: 08820 BUSINESS PHONE: 9087823431 MAIL ADDRESS: STREET 1: 43 EMERY AVE CITY: FLEMINGTON STATE: NJ ZIP: 08822 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Under the Securities Act of 1934 (Amendment No. _____________)* FLEMINGTON PHARMACEUTICAL CORPORATION - ------------------------------------------------------------------------------ (Name of Issuer) Common Stock, $ .01 par value - ------------------------------------------------------------------------------ (Title of Class of Securities) 339280 10 9 --------------------------- (CUSIP Number) - ------------------------------ ------------------------ CUSIP NO. 339280 10 9 13G Page 2 of 5 Pages ----------- - ------------------------------ ------------------------ - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON John J. Moroney ###-##-#### - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - ------------------------------------------------------------------------------ 5 SOLE VOTING POWER 800,000 ---------------------------------------------------- NUMBER OF SHARES EACH 6 SHARED VOTING POWER BENEFICIALLY 73,080 ---------------------------------------------------- OWNED BY 7 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 800,000 ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 73,080 - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 873,080 - ------------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 22.5% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* IN - ------------------------------------------------------------------------------ -2- Item 1. (a) Name of Issuer: Flemington Pharmaceutical Corporation (b) Address of Issuer's Principal Executive Offices: 43 Emery Avenue, Flemington, New Jersey 08822 Item 2. (a) Name of Person Filing: John J. Moroney (b) Address: 44 Rugen Drive, Harrington Park, New Jersey 07640 (c) Citizenship: U.S.A. (d) Title of Class of Securities: Common Stock, $.01 par value (e) CUSIP Number: 339280 10 9 Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-l(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: Not Applicable. (a) [ ] Broker or Dealer registered under Section 15 of the Act (b) [ ] Bank as defined in section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in section 3(a)(19) of the act (d) [ ] Investment Company registered under section 8 of the Investment Company Act (e) [ ] Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see ss. 240.13d-1(b)(1)(ii)(F) (g) [ ] Parent Holding Company, in accordance with ss.240.13d-l(b)(ii)(G) (h) [ ] Group, in accordance with ss. 240.13d-1(b)(1)(ii)(H) Item 4. OWNERSHIP (a) Amount Benefically Owned: 873,080 (b) Percent of Class: 22.5% -3- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 650,000 (ii) shared power to vote or to direct the vote: 223,080 (iii) sole power to dispose or to direct the disposition of: 650,000 (iv) shared power to dispose or to direct the disposition of: 223,080 Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not Applicable. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, checkthe following [ ]. Item 6. OWNERSHIP OF MORE THAT FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not Applicable. Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable. Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not Applicable. Item 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable. Item 10. CERTIFICATION: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. -4- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct March 9, 1998 ------------------------------- (date) /s/ John J. Moroney -------------------------------- Signature John J. Moroney, Chairman of the Board -------------------------------------- Name/Title -5- -----END PRIVACY-ENHANCED MESSAGE-----